Based on evidence presented and consultation responses, the UK National Screening Committee (UK NSC) has endorsed the use of digital pathology for histopathology as a permissive modification in the bowel cancer, breast and cervical screening programmes.
The committee was satisfied that digital pathology represents a safe optional alternative to light microscopy for commissioners and providers of diagnostic pathways in the 3 cancer screening programmes.
